phenethyl isothiocyanate has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Chiao, JW; Liu, XM; Wang, LG | 1 |
| He, M; Kawamura, T; Vanaja, DK; Yin, P; Young, CY | 1 |
| Kang, L; Wang, ZY | 1 |
4 other study(ies) available for phenethyl isothiocyanate and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
Topics: Androgen Receptor Antagonists; Anticarcinogenic Agents; Cell Line, Tumor; Cycloheximide; Humans; Isothiocyanates; Leupeptins; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Sp1 Transcription Factor; Transcription, Genetic | 2006 |
Phenethyl isothiocyanate induces cell cycle arrest and reduction of alpha- and beta-tubulin isotypes in human prostate cancer cells.
Topics: Anticarcinogenic Agents; Antioxidants; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cysteine; Flow Cytometry; G2 Phase; Humans; Isothiocyanates; Leupeptins; Male; Prostatic Neoplasms; Protein Isoforms; Tubulin | 2009 |
Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Genome, Human; Humans; Isothiocyanates; Leupeptins; Phosphorylation; Signal Transduction | 2010 |